Clinical trial
Safety and Tolerability of I-040302 in Children and Young Adults With Solitary…
NCT00459641 · Kuros Biosurgery AG, Industry · Withdrawn
Key facts
| NCT number | NCT00459641 |
|---|---|
| Title | Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts |
| Official title | A Phase 2 Randomised, Open-label, Multi-centre Ascending Dose Study of the Efficacy, Safety and Tolerability of I-040302 Versus Control Injection (Bone Marrow Aspirate or Steroids) in Children and Young Adults With Solitary Bone Cysts |
| Lead sponsor | Kuros Biosurgery AG, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bone Cysts |
| Intervention type | Drug, Other |
| Interventions | I-040302, Standard of Care |
| Enrollment | 0 |
| Start date | Dec 1, 2012 |
| Primary completion | Jun 1, 2014 |
| Completion | Jul 1, 2019 |
| First posted | Apr 12, 2007 |
| Last update posted | Jul 17, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: